SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Mesenteric Venous Thrombosis Treatment Outcomes and Prognosis: Scoping Review with ☸️SAIMSARA

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsarae883c7a8

Editorial note
• Last update: 2026-11-13 13:17:39
What is this paper about
Mesenteric venous thrombosis can be life-threatening, yet earlier diagnosis and evolving treatment strategies are transforming patient outcomes—with one study reporting mortality falling from 39% to 11%. Drawing on 436 scientific references, this review reveals what the evidence says about anticoagulation, endovascular interventions, risk factors, and long-term prognosis—unlock the full review to explore the findings.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Generated with SAIMSARA v5.3

Abstract: To synthesize current evidence regarding mesenteric venous thrombosis. The review uses 436 references and builds its evidence map from 1058 original studies with 159421 total participants/sample observations (topic-deduplicated ΣN). This scoping review suggests that mesenteric venous thrombosis is best approached as a high-risk yet increasingly treatable splanchnic thrombosis in which early cross-sectional imaging and prompt anticoagulation form the management core, with escalation reserved for threatened bowel. Anticoagulation, including both vitamin K antagonists and direct oral agents, was associated with favorable recanalization and low recurrence, and a medical-first policy was associated with reduced mortality from 39% to 11%. Outcomes appear more favorable than arterial mesenteric ischemia, though early mortality and progression to portal hypertensive sequelae remain clinically important. Because the evidence is dominated by case series and uncontrolled cohorts without randomized comparisons, these signals should be interpreted as descriptive patterns rather than confirmed effects. Future prospective comparative trials using standardized recanalization, bowel-preservation, and bleeding endpoints are needed to clarify optimal anticoagulant choice, duration, and the role of endovascular escalation.

Keywords: Mesenteric venous thrombosis; Superior mesenteric vein; Portomesenteric thrombosis; Anticoagulation therapy; Mesenteric ischemia; Computed tomography; Thrombophilia; Appendicitis; Splenectomy; COVID-19

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (435)

Unlock the full paper to view the complete Reference Index.